Diabetes http://www.globalpost.com/taxonomy/term/29781/all en REFILE-Insulin-requiring diabetes up in young children: study http://www.globalpost.com/dispatch/news/thomson-reuters/130203/insulin-requiring-diabetes-young-children-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>(Adds dropped word 'five' in lead)</p> <p>Feb 4 (Reuters) - The number of cases of insulin-requiring type 1 diabetes rose sharply in children under the age of five in Philadelphia over a two decade span, paralleling increases seen across the United States and in Europe, according to a U.S. study.</p> <p>Researchers whose work appeared in the journal Diabetes Care found that the number of children under five diagnosed with type 1 diabetes increased 70 percent in 2005 from 1985, when a registry of such patients was begun.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130203/insulin-requiring-diabetes-young-children-study" target="_blank">read more</a></p> Diabetes Endocrine system Medicine Thomson Reuters Mon, 04 Feb 2013 00:31:11 +0000 5744891 at http://www.globalpost.com Salsa singer Santa Rosa wants to increase diabetes awareness among Hispanics http://www.globalpost.com/dispatch/news/agencia-efe/130305/salsa-singer-santa-rosa-wants-increase-diabetes-awareness-among-his <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agencia EFE </div> </div> </div> <!--paging_filter--><p>New York, Mar 5 (EFE).- Salsa singer Gilberto Santa Rosa acts as spokesman for the educational campaign "Todo Diabetico Cuenta" (Every Diabetic Counts), which seeks to inform and raise awareness about an illness that affects a disproportionate number of Latinos.</p> <p>"The biggest complication of this illness is misinformation. The purpose of the campaign is to inform people about the condition and how to improve their quality of life. People like me need that information," the singer, who has the disease, told Efe.</p> <p><a href="http://www.globalpost.com/dispatch/news/agencia-efe/130305/salsa-singer-santa-rosa-wants-increase-diabetes-awareness-among-his" target="_blank">read more</a></p> Diabetes Gilberto Santa Rosa Gilberto Santa Rosa Social Issues Agencia EFE Tue, 05 Mar 2013 16:01:25 +0000 5773994 at http://www.globalpost.com USFDA approves safer diabetes drug which acts on kidneys http://www.globalpost.com/dispatch/news/asianet/130406/usfda-approves-safer-diabetes-drug-which-acts-kidneys <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Asianet </div> </div> </div> <!--paging_filter--><p></p><P> A novel anti-diabetic drug that lowers blood glucose levels by acting on the kidneys, instead of the liver or the pancreas, has been approved by the USFDA. The drug, Invokana (Canagliflozin), works by blocking the reabsorption of glucose by the kidney, increasing glucose excretion and lowering blood glucose levels in diabetics.</p> <p><a href="http://www.globalpost.com/dispatch/news/asianet/130406/usfda-approves-safer-diabetes-drug-which-acts-kidneys" target="_blank">read more</a></p> Diabetes Endocrine system Medicine Asianet Sat, 06 Apr 2013 16:20:38 +0000 Asianet 5804126 at http://www.globalpost.com Novo Nordisk posts better-than-expected earnings http://www.globalpost.com/dispatch/news/afp/130501/novo-nordisk-posts-better-expected-earnings <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Danish pharmaceutical group Novo Nordisk, the world's biggest producer of insulin for diabetes sufferers, on Wednesday topped analyst profit expectations for its first quarter of 2013</p> <p>From January to March, the group posted a net profit of 5.982 billion Danish kroner (802 million euros), as it enjoyed strong sales of its diabetic drug Victoza and "modern insulins."</p> <p>Analysts polled by Dow Jones Newswires predicted 5.85 billion kroner in net profit.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130501/novo-nordisk-posts-better-expected-earnings" target="_blank">read more</a></p> Diabetes Endocrine system Novo Nordisk Peptide hormones AFP Wed, 01 May 2013 07:45:20 +0000 5829074 at http://www.globalpost.com Chinese Canadians may have higher diabetes risk that previously thought: study http://www.globalpost.com/dispatch/news/the-canadian-press/130530/chinese-canadians-may-have-higher-diabetes-risk-previously-t <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>TORONTO - Canadians of Chinese descent may be at higher risk of developing diabetes than their historically low obesity rates would indicate, new research suggested Thursday.</p> <p>A study from the Institute for Clinical Evaluative Sciences found that the rate of diabetes diagnoses soared sharply among Ontario's Chinese Canadian population over a 10-year period, while the increase in cases among their European counterparts was comparatively small. The findings were published Thursday in the journal Diabetes Care.</p> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130530/chinese-canadians-may-have-higher-diabetes-risk-previously-t" target="_blank">read more</a></p> Baiju Shah Diabetes Health Human Interest Labor Nutrition Social Issues The Canadian Press Thu, 30 May 2013 14:33:21 +0000 5848782 at http://www.globalpost.com U.S. court finds Novo Nordisk Prandin diabetes drug patent invalid http://www.globalpost.com/dispatch/news/thomson-reuters/130618/us-court-finds-novo-nordisk-prandin-diabetes-drug-patent-invali <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>(Reuters) - A U.S. appeals court found the patent on Novo Nordisk's Prandin diabetes drug in combination with metformin to be invalid, paving the way for introduction of a generic version of the medicine, the Danish drugmaker said on Tuesday.</p> <p>In a 2-1 ruling, the U.S. Court of Appeals affirmed a district court ruling handed down in 2011, the company said.</p> <p>Novo said it still believes the patent to be valid and was reviewing the ruling.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130618/us-court-finds-novo-nordisk-prandin-diabetes-drug-patent-invali" target="_blank">read more</a></p> Chemistry Diabetes Organic chemistry Thomson Reuters Tue, 18 Jun 2013 21:00:51 +0000 5860532 at http://www.globalpost.com Medtronic takes 'first step' toward U.S. sale of artificial pancreas http://www.globalpost.com/dispatch/news/thomson-reuters/130622/medtronic-takes-first-step-toward-us-sale-artificial-pancreas <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Julie Steenhuysen</p> <p>CHICAGO (Reuters) - Type 1 diabetics, who run the risk of dangerously low blood sugar, may be a step closer to getting help from a crude artificial pancreas device that can read blood sugar levels and automatically turn off the flow of insulin after a clinical trial showed the device is safe.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130622/medtronic-takes-first-step-toward-us-sale-artificial-pancreas" target="_blank">read more</a></p> Diabetes Endocrine system Health Medicine Technology Thomson Reuters Sat, 22 Jun 2013 15:31:47 +0000 5864502 at http://www.globalpost.com Type 1 diabetes vaccine shows promise in early study: researchers http://www.globalpost.com/dispatch/news/thomson-reuters/130626/type-1-diabetes-vaccine-shows-promise-early-study-researchers <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Julie Steenhuysen</p> <p>CHICAGO (Reuters) - An early stage study suggests an experimental vaccine may be able to tame bits of the immune system that go haywire in people with type 1 diabetes, offering hope for a new way to delay or prevent the autoimmune disease, researchers said on Wednesday.</p> <p>For more than four decades, scientists have tried different ways of manipulating the immune system to stop the destruction of insulin-producing cells that is responsible for type 1 diabetes. The disease affects as many as 3 million Americans.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130626/type-1-diabetes-vaccine-shows-promise-early-study-researchers" target="_blank">read more</a></p> Biology Business Diabetes Endocrine system Health Technology Thomson Reuters Wed, 26 Jun 2013 18:32:44 +0000 5868393 at http://www.globalpost.com Sanofi wins diabetes drug approval in Japan http://www.globalpost.com/dispatch/news/thomson-reuters/130628/sanofi-wins-diabetes-drug-approval-japan <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>PARIS (Reuters) - French drugmaker Sanofi said it won approval from the Japanese government for its Lyxumia drug for the treatment of Type 2 diabetes in combination with basal insulin.</p> <p>Lyxumia is part of a new class of diabetes treatments called GLP-1 analogues which prompt the body to release insulin when a diabetic's blood sugar level climbs too high.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130628/sanofi-wins-diabetes-drug-approval-japan" target="_blank">read more</a></p> Diabetes Endocrine system Peptide hormones Thomson Reuters Fri, 28 Jun 2013 07:01:28 +0000 5870083 at http://www.globalpost.com Timing of first solid food tied to child diabetes risk http://www.globalpost.com/dispatch/news/thomson-reuters/130712/timing-first-solid-food-tied-child-diabetes-risk <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Kathryn Doyle</p> <p>NEW YORK (Reuters Health) - When babies already at increased risk for type 1 diabetes had their first solid foods before four months of age or after six months, their chances of developing the disorder at least doubled, according to a new study.</p> <p>Four to six months is the recommended age window for all kids to start on solid foods, but the new results suggest timing could be even more important for babies at high risk for type 1 diabetes (T1D) because of genetic susceptibility.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130712/timing-first-solid-food-tied-child-diabetes-risk" target="_blank">read more</a></p> Diabetes Endocrine system Hospitality Medicine Technology Thomson Reuters Fri, 12 Jul 2013 19:34:01 +0000 5882695 at http://www.globalpost.com DNA flaw boosts cancer risk from diabetes http://www.globalpost.com/dispatch/news/afp/130714/habitat-loss-doubles-coastal-flood-impact-study <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>A DNA flaw may explain why people with Type 2 diabetes are more prone to blood cancers than the rest of the population, a study said Sunday.</p> <p>Doctors have long known that Type 2 diabetes is associated with leukaemia and lymphoma, but the reasons for this have been unclear.</p> <p>Researchers in France and Britain, looking at blood samples from nearly 7,500 people, including 2,200 patients with Type 2 diabetes, suggest the answer lies in cellular mutations called clonal mosaic events (CMEs).</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130714/habitat-loss-doubles-coastal-flood-impact-study" target="_blank">read more</a></p> Diabetes Health Medicine AFP Sun, 14 Jul 2013 19:37:12 +0000 5883782 at http://www.globalpost.com Elderly with diabetes 50% likelier to have disability http://www.globalpost.com/dispatch/news/afp/130723/elderly-diabetes-50-likelier-have-disability <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Older adults with diabetes are between 50 and 80 percent likelier to have a disability compared to people without the disease, according to a review published on Wednesday.</p> <p>Researchers at the Baker IDI Heart and Diabetes Institute in Melbourne, Australia, trawled through more than 3,200 previously published studies that explored the link between diabetes and disability.</p> <p>They narrowed the catch down to 26 studies that compared like with like.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130723/elderly-diabetes-50-likelier-have-disability" target="_blank">read more</a></p> Diabetes Health Medicine AFP Tue, 23 Jul 2013 23:33:33 +0000 5891804 at http://www.globalpost.com FDA: diabetes test strip maker recalls 62 million products that can give incorrect readings http://www.globalpost.com/dispatch/news/the-canadian-press/130731/fda-diabetes-test-strip-maker-recalls-62-million-products--0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>WASHINGTON - The Food and Drug Administration is warning patients with diabetes about the recall of 62 million glucose test strips used to measure blood sugar levels.</p> <p>Nova Diabetes Care announced the recall Friday after discovering that some of the strips can show incorrect, abnormally high blood sugar readings. An incorrect reading could potentially lead to dangerous medication errors for patients.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.globalpost.com/terms-use#cp">Copyright 2013 Canadian Press.</a></p> <p>All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.</p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130731/fda-diabetes-test-strip-maker-recalls-62-million-products--0" target="_blank">read more</a></p> Blood tests Diabetes Disaster Endocrine system The Canadian Press Wed, 31 Jul 2013 20:32:48 +0000 5899234 at http://www.globalpost.com FDA: diabetes test strip maker recalls 62 million products that can give incorrect readings http://www.globalpost.com/dispatch/news/the-canadian-press/130731/fda-diabetes-test-strip-maker-recalls-62-million-products-ca <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>WASHINGTON - The Food and Drug Administration is warning patients with diabetes about a recall of up to 62 million glucose test strips used to measure blood sugar levels that can show incorrect, abnormally high blood sugar readings.</p> <p>Nova Diabetes Care announced the recall Friday. An incorrect reading could potentially lead to dangerous medication errors for patients.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.globalpost.com/terms-use#cp">Copyright 2013 Canadian Press.</a></p> <p>All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.</p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/130731/fda-diabetes-test-strip-maker-recalls-62-million-products-ca" target="_blank">read more</a></p> Diabetes Disaster Endocrine system Medicine Technology The Canadian Press Wed, 31 Jul 2013 20:31:45 +0000 5899230 at http://www.globalpost.com High blood sugar tied to dementia in non-diabetics http://www.globalpost.com/dispatch/news/thomson-reuters/130807/high-blood-sugar-tied-dementia-non-diabetics <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Gene Emery</p> <p>NEW YORK (Reuters Health) - Elderly people with high blood sugar - but not high enough to be diabetic - face a slightly greater risk of developing dementia, according to a new study of over 2,000 volunteers.</p> <p>The research, published in the New England Journal of Medicine, does not prove that high glucose levels directly cause dementia.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130807/high-blood-sugar-tied-dementia-non-diabetics" target="_blank">read more</a></p> Diabetes Health Medicine Thomson Reuters Thu, 08 Aug 2013 00:17:19 +0000 5905045 at http://www.globalpost.com